Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting of Human Antigen-Presenting Cell Subsets

18 Jul 2013

Abstract excerpt

Antigen-presenting cells are a heterogeneous group of cells that are characterized by their functional specialization. Consequently, targeting specific antigen-presenting cell subsets offers opportunities to induce distinct T cell responses. Here we report on the generation and use of nanobodies (Nbs) to target lentivectors specifically to human lymph node-resident myeloid dendritic cells, demonstrating that Nbs...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immunotherapy and Immune Responses
Share to Monoclonal and Polyclonal Antibodies Research
Share to T-cell and B-cell Immunology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23864630
DOI: 10.1128/jvi.01498-13

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting of Human Antigen-Presenting Cell SubsetsPMID 23864630Read ↗

The Application of Nanobody in CAR-T TherapySemantic proximity Read ↗

Engineering Artificial Antigen-presenting Cells to Express a Diverse Array of Co-stimulatory MoleculesSemantic proximity Read ↗

Immunization delivered by lentiviral vectors for cancer and infectious diseasesSemantic proximity Read ↗

Improved targeting of human CD4+ T cells by nanobody-modified AAV2 gene therapy vectorsSemantic proximity Read ↗

Exclusive Transduction of Human CD4+ T Cells upon Systemic Delivery of CD4-Targeted Lentiviral VectorsSemantic proximity Read ↗

Targeting human dendritic cells in situ to improve vaccines.Semantic proximity Read ↗

Nanobody-based CAR-T cells for cancer immunotherapySemantic proximity Read ↗

Transduction of Human T Cell Subsets with Lentivirus.Semantic proximity Read ↗

Lentivirally transduced dendritic cells as a tool for cancer immunotherapySemantic proximity Read ↗

A genetically engineered therapeutic lectin inhibits human influenza A virus infection and sustains robust virus-specific CD8 T cell expansionSemantic proximity Read ↗

Functional antigen presenting cells generated from human dendritic cells (DC) derived induced pluripotent stem cell linesSemantic proximity Read ↗

Efficient Nanovaccine Delivery in Cancer ImmunotherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.